Camrelizumab in Patients With Unresectable Hepatocellular Carcinoma
Clinical trial NCT04947956 · UNKNOWN
Trial details
- NCT number
- NCT04947956
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-01
- Primary completion
- 2023-09-01
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.